COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,141 Articles (22,693 medRxiv, 8,448 bioRxiv)

Most recent first Previous |  Page 40: Articles 391-400  | Next

Predicting Future SARS-CoV-2 Mutations using Deep Learning
Ayaz, H., Ibrahimzada, A. R., Adebali, O., Fejzullahu, A., Azgari, C., Baysan, M., Buyukbingol, M. E., Demir, G., Karlik, E., Ozpolat, B., CAKMAK, A.
10.1101/2025.07.12.664533 — Posted: 2025-07-15
Integrated Systems Vaccinology Reveals Distinct Metabolic Responses to SARS-CoV-2 Infection and DNA-Based Vaccines in Ferrets
Ahlen, G., Ambikan, A., Mikaeloff, F., Rezene, S., Yan, J., Nikouyan, N., Revanna, C. B., Appelberg, S., Mirazimi, A., Sallberg, M., Neogi, U., Gupta, S.
10.1101/2025.07.11.664150 — Posted: 2025-07-14
The effect of pre-booked appointments on COVID-19 vaccine uptake during the 2023 autumn campaign in the Netherlands: a regression discontinuity analysis
Haverkate, M., van de Kassteele, J., van den Hof, S., Sanders, J., Lambooij, M., de Bruin, M., de Melker, H., Hahne, S.
10.1101/2025.07.10.25331000 — Posted: 2025-07-11
Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness
Ma, K., Surie, D., Dean, N. E., Paden, C. R., Thornburg, N., Dawood, F. S.
10.1101/2025.07.10.25331291 — Posted: 2025-07-11
The Unreliability of Estimated Release Dates in Hospital Drug Shortage Management: A Case Study of Hospital Pharmacy Operations During the COVID-19 Pandemic
Chicoine, N., Griffin, J.
10.1101/2025.07.10.25331166 — Posted: 2025-07-11
Bimodal Contact Reductions and Social Homophily during COVID-19
Paltra, S., Stellbrink, L., Friedel, J., Kretzschmar, M. E., Mortaga, M., Nagel, K., Nunner, H., Calero Valdez, A., Priesemann, V.
10.1101/2025.07.10.25331264 — Posted: 2025-07-11
Quantifying the impact of the COVID-19 pandemic on invasive bacterial diseases across 27 countries and territories: prospective surveillance by the IRIS Consortium
Shaw, D., Brueggemann, A. B.
10.1101/2025.07.10.25331197 — Posted: 2025-07-11
Deciphering the Mechanistic Continuum of Broadly Neutralizing Class 4 Antibodies Targeting Conserved Cryptic Epitopes of the SARS-CoV-2 Spike Protein : Operating at the Intersection of Binding, Allostery and Immune Escape
Alshahrani, M., Parikh, V., Foley, B., Verkhivker, G.
10.1101/2025.07.10.664240 — Posted: 2025-07-11
Impact of Preexisting Rare Diseases on COVID-19 Severity, Reinfection, and Long COVID, and the Modifying Effects of Vaccination and Antiviral Therapy: A Retrospective Study from the N3C Data Enclave
Yadaw, A. S., Sahner, D. K., Sid, E., Chew, E. Y., Pichard, D. C., Mathe, E. A.
10.1101/2025.07.09.25331138 — Posted: 2025-07-10
Evaluation of the SEIMC score as a death predictor of SARS-CoV-2 pneumonia in vaccinated patients: a validation cohort
Gil-Rodriguez, J., Aranda-Laserna, P., Montero-Alonso, M. A., Martinez de Victoria Carazo, J., Fernandez Reyes, D., Guirao-Arrabal, E.
10.1101/2025.07.09.25331178 — Posted: 2025-07-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).